AstraZeneca vaults to the front of the Covid-19 vaccine race, teaming up to globalize Oxford candidate

Amber Tong

Before last week, AstraZeneca was watching with the rest of the world as researchers at Oxford University’s Jenner Institute began pushing their Covid-19 vaccine in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

AstraZeneca vaults to the front of the Covid-19 vaccine race, teaming up to globalize Oxford candidate

Amber Tong

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

As­traZeneca vaults to the front of the Covid-19 vac­cine race, team­ing up to glob­al­ize Ox­ford can­di­date

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

AstraZeneca vaults to the front of the Covid-19 vaccine race, teaming up to globalize Oxford candidate